go to main content
27 September 2018

On 17 September, David Burger, professor of clinical pharmacy, together with colleagues from the United Kingdom, Uganda and Zimbabwe, received the "Outstanding Research Team" award from the European - Developing Countries Clinical Trial Partnership (EDCTP).

The EDCTP is a European program which is part of  the Horizon 2020 subsidy program. The prize (€ 50,000 and a goblet) was awarded to the CHAPAS project, which stands for Children with HIV in Africa: Pharmacokinetic and Adherence Studies, and was established by Burger a.o. in 2005 to improve treatment options for children with HIV in Africa. The 4th edition of CHAPAS is currently underway, with contributions from the Pharmacy by Angela Colbers and PhD candidate Hylke Waalewijn.

David Burger is member of theme Infectious diseases and global health. 
 

  • Want to know more about these subjects? Click on the buttons below for more news.

    Pharmacy

Related news items

The European Hector Research Award in HIV 2021 awarded to Angela Colbers and David Burger

2 November 2021 On Friday 29 October 2021, during the 18th European AIDS Conference in London, the Hector Research Award for the best scientific article related to clinical or epidemiological HIV research was presented to Angela Colbers and David Burger, both working in the Pharmacy of the RadboudUMC. read more

Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis

25 January 2021

Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.

read more

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2)

12 May 2020 In Lancet HIV RIHS researchers Angela Colbers and David Burger showed in an open-label, randomized controlled trial, that, when initiated in the 3rd trimester of pregnancy, achievement of VL <50cp/mL at delivery was more likely with dolutegravir-based therapy than with efavirenz-based regimens. read more

The effect of pregnancy on the pharmacokinetics of dolutegravir in women living with HIV

17 March 2020 In Clinical infectious diseases RIHS researchers Pauline Bollen, Jolien Freriksen, Angela Colbers and David Burger together with researchers of the PANNA network showed that dolutegravir use in pregnancy results in effective plasma concentrations. read more

Importance of prospective studies in pregnant and breastfeeding women living with HIV

14 March 2019 In Clinical Infectious Diseases Angela Colbers, Stein Schalkwijk and David Burger give considerations on how to effectively evaluate aspects of clinical pharmacology required for safe and effective treatment to optimize pharmacotherapy during pregnancy and breastfeeding. read more

Beyond the scientist: Roger Brüggemann

13 November 2018 Roger, who subscribed for the national pilot academy in 1992, eventually became a hospital pharmacist and associate professor of clinical pharmacology. This summer he became a “Cinglé du Ventoux”. read more